Perphenazine and Amitriptyline Hydrochloride Tablets
» Perphenazine and Amitriptyline Hydrochloride Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amounts of perphenazine (C21H26ClN3OS) and amitriptyline hydrochloride (C20H23N·HCl).
Packaging and storage— Preserve in well-closed containers.
USP Reference standards 11
USP Amitriptyline Hydrochloride RS
.
USP Perphenazine RS
.
note—Throughout the following procedures, protect test or assay specimens, the USP Reference Standard, and solutions containing them, by conducting the procedures without delay, under subdued light, or using low-actinic glassware.
Identification— Transfer a portion of powdered Tablets, equivalent to about 40 mg of perphenazine, to a 100-mL volumetric flask containing about 50 mL of alcohol. Agitate for 20 minutes, add alcohol to volume, mix, and filter or centrifuge. Separately prepare two Standard solutions containing 0.4 mg per mL of USP Perphenazine RS and USP Amitriptyline Hydrochloride RS, respectively, in alcohol. Separately apply 5 µL of the test solution and 5 µL of each Standard solution to a thin-layer chromatographic plate (see Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel mixture. Develop the chromatogram using a solvent system consisting of a mixture of cyclohexane, ethyl acetate, and diethylamine (85:25:5) until the solvent front has moved about 15 cm. Remove the plate from the developing chamber, air-dry for 20 minutes, and examine the plate under short-wavelength UV light: the RF values of the principal spots obtained from the test solution correspond to those obtained from the Standard solutions.
Dissolution 711
Medium: 0.1 N hydrochloric acid; 900 mL.
Apparatus 2: 50 rpm.
Time: 60 minutes.
Procedure— [note—Due to potential decrease in the recovery of perphenazine when multiple injections are made from a vial, no more than two withdrawals should be made from any single vial.] Determine the amounts of perphenazine and amitriptyline hydrochloride in solution in filtered portions of the solution under test, in comparison with a Standard solution having known concentrations of USP Perphenazine RS and USP Amitriptyline Hydrochloride RS in the same medium, as directed for Procedure in the Assay.
Tolerances— Not less than 75% (Q) of the labeled amounts of perphenazine (C21H26ClN3OS) and amitriptyline hydrochloride (C20H23N·HCl) is dissolved in 60 minutes.
Uniformity of dosage units 905: meet the requirements for Content uniformity with respect to perphenazine and to amitriptyline hydrochloride.
Assay—
Mobile phase— Prepare a filtered and degassed mixture of water, acetonitrile, methanol, and methanesulfonic acid (490:310:200:2). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Dissolve an accurately weighed quantity of USP Perphenazine RS in methanol, and dilute quantitatively with methanol to obtain a solution having a known concentration of about 0.8 mg per mL (Solution P). Transfer 4J mg of USP Amitriptyline Hydrochloride RS to a 50-mL volumetric flask, J being the ratio of the labeled amount, in mg, of amitriptyline hydrochloride to the labeled amount, in mg, of perphenazine per Tablet. Add 5.0 mL of Solution P and 20 mL of 0.2 N acetic acid, shake, and sonicate to dissolve the USP Reference Standards. Dilute with methanol to volume, and mix. Pipet 25 mL of this solution into a 100-mL volumetric flask, dilute with a mixture of methanol and 0.04 N acetic acid (3:2) to volume, and mix to obtain a Standard preparation having known concentrations of about 20 µg of USP Perphenazine RS per mL and about 20J µg of USP Amitriptyline Hydrochloride RS per mL.
Assay preparation— Transfer 10 Tablets to a 250-mL volumetric flask, add 100 mL of 0.2 N acetic acid, and shake the mixture until the Tablets have disintegrated. Add methanol to volume, mix, and filter. Dilute an accurately measured volume (VF mL) of the clear filtrate quantitatively with a mixture of methanol and 0.04 N acetic acid (3:2) to obtain a solution (VA mL) containing about 20 µg of perphenazine per mL, and filter through a membrane filter.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate is about 1 mL per minute, and is adjusted until the relative retention times for perphenazine and amitriptyline are about 1 and 1.5, respectively. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation is not more than 2.0% for replicate injections, and the resolution, R, between perphenazine and amitriptyline is not less than 4.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of perphenazine (C21H26ClN3OS) in each Tablet taken by the formula:
0.25(C / 10)(VA / VF)(rU / rS)
in which C is the concentration, in µg per mL, of USP Perphenazine RS in the Standard preparation, VA is the volume, in mL, of the Assay preparation, VF is the volume, in mL, of the filtrate taken for the Assay preparation, and rU and rS are the responses of the perphenazine peaks obtained from the Assay preparation and the Standard preparation, respectively. Calculate the quantity, in mg, of amitriptyline hydrochloride (C20H23N·HCl) taken by the same formula, reading amitriptyline hydrochloride instead of perphenazine.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ravi Ravichandran, Ph.D.
Senior Scientist
1-301-816-8330
(MDPP05) Monograph Development-Psychiatrics and Psychoactives
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
1-301-816-8106
(BPC05) Biopharmaceutics05
USP32–NF27 Page 3262
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.